BCL2 and gastric cancer: Moreover, miR-204 increased the sensitivity of GC cells to treatment with 5-fluorouracil and oxaliplatin by targeting Bcl-2, whereas restoration of Bcl-2 protein counteracted this response to 5-fluorouracil [47].